Skip to main content

Table 1 Histopathological characteristics of EC

From: Risk stratification of endometrial cancer and lymph node metastases prediction using 18F-FDG PET/CT: role of metabolic tumor volume and total lesion glycolysis

Histological characteristic Number of cases (%)
Histopathological type
Non-endometrioid 5/33 (15.2%)
Endometrioid 28/33 (84.8%)
Histopathological grade
G 1 15/33 (45.5%)
G 2 11/33 (33.3%)
G 3 7/33 (21.2%)
FIGO stage
IA 15/33 (45.5%)
IB 6/33 (18.2%)
II 2/33 (6.1%)
IIIB 1/33 (3%)
IIIC 7/33 (21.2%)
IVB 2/33 (6%)
Myometrial invasion
 < 50% 15/33 (45.5%)
 > 50% 18/33 (54.5%)
LVSI
Yes 15/33 (45.5%)
No 18/33 (54.5%)
LNMs
Yes 9/33 (27.3%)
No 24/33 (72.7%)
Risk stratification
Low risk 11/33 (33.3%)
High risk 22/33 (66.7%)
  1. LVSI, Lymphovascular space invasion, LNMs, Lymph nodes metastases